celltech group the independent biotechnology company halved pretax losses and intends to seek a listing for its shares by 1994 a loss of pounds 658m pounds 125m was incurred for the year to september 30 on turnover of pounds 17m pounds 199m the company has completed a restructuring programme and its research is now focused on projects aimed at large markets such as cancer therapy and transplant technology